1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Changzhou Qianhong Biopharma CO.,LTD

Changzhou Qianhong Biopharma CO.,LTD

002550.SZ
Changzhou Qianhong Biopharma CO.,LTDCN flagShenzhen Stock Exchange
6.93
CNY
+0.09
- -
8.49BMarket Cap

Total Valuation

Changzhou Qianhong Biopharma CO.,LTD carries a market capitalization of 8.49B, placing it among publicly traded companies globally. Its enterprise value stands at 9.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.49B
Enterprise Value9.75B

Share Statistics

Changzhou Qianhong Biopharma CO.,LTD currently has 1.28B shares outstanding.

Shares Outstanding1.28B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Changzhou Qianhong Biopharma CO.,LTD trades at a trailing price-to-earnings ratio of 24.34. The price-to-sales ratio is 6.85, and the price-to-book ratio stands at 4.32.

PE Ratio24.34
PS Ratio6.85
PB Ratio4.32
P/TBV Ratio4.44
P/FCF Ratio81.73
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Changzhou Qianhong Biopharma CO.,LTD trades at an EV/EBITDA multiple of 30.16 and an EV/FCF ratio of 75.61. The EV/Sales ratio of 6.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.16 provides insight into valuation relative to core operating earnings.

EV / Sales6.36
EV / EBITDA30.16
EV / EBIT30.16
EV / FCF75.61

Financial Position

Changzhou Qianhong Biopharma CO.,LTD maintains a current ratio of 11.01, meaning it holds 11.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.74, indicating moderate leverage, while an interest coverage ratio of 551.70 demonstrates strong ability to service its debt obligations.

Current Ratio11.01
Quick Ratio4.63
Debt / Equity0.74
Debt / EBITDA0.06
Interest Coverage551.70

Financial Efficiency

Changzhou Qianhong Biopharma CO.,LTD posts a return on equity of 18.68 and a return on invested capital of 10.79.

Return on Equity (ROE)18.68
Return on Assets (ROA)15.68
Return on Invested Capital (ROIC)10.79
Return on Capital Employed (ROCE)19.61
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.62

Taxes

Over the trailing twelve months, Changzhou Qianhong Biopharma CO.,LTD has paid 77.16M in income taxes, reflecting an effective tax rate of 15.96.

Income Tax77.16M
Effective Tax Rate15.96

Stock Price Statistics

Changzhou Qianhong Biopharma CO.,LTD's stock has declined approximately -22.04724% over the past 52 weeks. The 50-day moving average sits at 6.51, while the 200-day moving average is 7.77.

Beta (5Y)N/A
52-Week Price Change-22.04724%
50-Day Moving Average6.51
200-Day Moving Average7.77
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Changzhou Qianhong Biopharma CO.,LTD generated 1.53B in revenue and converted that into 431.29M in net income, yielding earnings per share of 0.33. EBITDA reached 323.27M, while operating income came in at 323.27M.

Revenue1.53B
Gross Profit871.57M
Operating Income323.27M
Pretax Income483.50M
Net Income431.29M
EBITDA323.27M
EBIT323.27M
Earnings Per Share (EPS)0.33

Balance Sheet

Changzhou Qianhong Biopharma CO.,LTD holds 758.81M in cash and equivalents against 19.42M in total debt, resulting in a net debt position of -593.97M. Total book value stands at 2.43B, with working capital of 1.64B providing operational flexibility.

Cash & Cash Equivalents758.81M
Total Debt19.42M
Net Debt-593.97M
Equity (Book Value)2.43B
Book Value Per Share1.94
Working Capital1.64B

Cash Flow

After subtracting -128.45M in capital expenditures, free cash flow totaled -128.45M - equivalent to -0.10 per share.

Operating Cash FlowN/A
Capital Expenditures-128.45M
Free Cash Flow-128.45M
FCF Per Share-0.10

Margins

Changzhou Qianhong Biopharma CO.,LTD operates with a gross margin of 56.88, reflecting its pricing power and cost economics. The operating margin of 21.10 and net profit margin of 28.14 provide insight into operational efficiency.

Gross Margin56.88
Operating Margin21.10
Pretax Margin31.55
Profit Margin28.14
EBITDA Margin21.10

Dividends & Yields

The company's payout ratio of 39.52 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.12
Dividend YieldN/A
Payout Ratio39.52
Shareholder Yield1.41
FCF Yield1.22

Stock Splits

Changzhou Qianhong Biopharma CO.,LTD's most recent stock split took place on May 31, 2016 with a 1:2 split ratio.

Last Split Date5/31/2016
Split Ratio1:2

Scores

Changzhou Qianhong Biopharma CO.,LTD posts an Altman Z-Score of 26.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score26.99